EC Number   |
Title |
Organism |
|---|
   3.4.16.2 | Identification of prolyl carboxypeptidase as an alternative enzyme for processing of renal angiotensin II using mass spectrometry |
Mus musculus |
| 3.4.16.2 | A digestive prolyl carboxypeptidase in Tenebrio molitor larvae |
Tenebrio molitor |
| 3.4.16.2 | A new class of prolylcarboxypeptidase inhibitors, part 1: discovery and evaluation |
Homo sapiens |
| 3.4.16.2 | A new class of prolylcarboxypeptidase inhibitors, part 1: discovery and evaluation |
Mus musculus |
| 3.4.16.2 | A new class of prolylcarboxypeptidase inhibitors, part 2: the aminocyclopentanes |
Homo sapiens |
| 3.4.16.2 | A new class of prolylcarboxypeptidase inhibitors, part 2: the aminocyclopentanes |
Mus musculus |
| 3.4.16.2 | Activity of lysosomal carboxypeptidase in aneurysmal aortic wall |
Homo sapiens |
| 3.4.16.2 | Application of HPLC-ESI-ITMS in the quality control of carboxyterminal sequence confirmation for the recombinant DNA product Hirudin Variant 3 |
Penicillium janthinellum |
| 3.4.16.2 | Characterization of carboxypeptidase a6, an extracellular matrix peptidase |
Homo sapiens |
| 3.4.16.2 | Deficiency in thrombin-activatable fibrinolysis inhibitor (TAFI) protected mice from ferric chloride-induced vena cava thrombosis |
Mus musculus |
